XML 105 R27.htm IDEA: XBRL DOCUMENT

Insider Trading Arrangements

3 Months Ended

12 Months Ended

Dec. 31, 2024

From time to time, our officers (as defined in Rule 16a–1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months

ended December 31, 2024, our officers and directors took the following actions with respect to 10b5-1 trading arrangements:

Trading Arrangement

Action

Date

Type of Trading Arrangement

Nature of Trading Arrangement

Total Shares to be Sold

Expiration Date

Natarajan Sethuraman (President of Research and Development)

Adopt

11/18/2024

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c)

Sale of the Company's common stock pursuant to the terms of the plan

115,834 (1)

6/15/2026

(1)For purposes of this disclosure, the shares included in this table reflect the aggregate maximum number of shares that may be sold under the 10b5-1 trading arrangement. The 10b5-1 trading arrangement covers RSUs and shares held by the officer. The actual number of shares that may be sold under the 10b5-1 trading arrangement will be calculated as RSU vesting to satisfy tax withholding obligations pursuant to the Company’s non-discretionary sell-to-cover requirement occurs.

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Natarajan Sethuraman [Member]

Trading Arrangements, by Individual

Name

Natarajan Sethuraman

Title

President of Research and Development